Form4insider filings, from the source

SEC Form 4 · accession 0001209191-18-002051

AMICUS THERAPEUTICS, INC. · FOLD

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Daphne Quimi
Officer — SVP, Finance
Period of report
Jan 2, 2018
Accepted (ET)
Jan 4, 2018 · 5:10 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001178879

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common stockF2Jan 2, 2018M8,000$14.7154A62,676D
Common stockF3Jan 2, 2018S8,000$14.7154D54,676D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Options (right to buy)$10.36Jan 2, 2018M8,000DFeb 3, 2010Feb 3, 2019Common stock8,0000D

Explanation of responses